Casi DeYoung

Casi DeYoung

Corporate Officer/Principal presso SHATTUCK LABS, INC.

Patrimonio netto: 509 951 $ in data 30/06/2026

55 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Casi DeYoung is currently Chief Business Officer at Shattuck Labs, Inc. since 2019.
Former roles include Operations Director-Oncology at Merck KGaA, Operations Director-Oncology at EMD Pharmaceuticals, Inc. from 2000 to 2005, Consulting Manager at Accenture Ltd., Vice President-Business Development at Reata Pharmaceuticals, Inc. from 2008 to 2013, Vice President-Business Development at ODC Therapy, Inc. from 2005 to 2008, Chief Business Officer at Mirna Therapeutics, Inc. from 2014 to 2017, and Chief Operating Officer & Vice President at ImmuneSensor Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Southwestern University and an MBA from McCombs School of Business.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
25/01/2026 73.480 ( 0,08% ) 509 951 $ 30/06/2026

Posizioni attive di Casi DeYoung

SocietàPosizioneInizio
SHATTUCK LABS, INC. Corporate Officer/Principal 01/12/2019

Precedenti posizioni note di Casi DeYoung

SocietàPosizioneFine
Direttore operativo 01/12/2019
Public Communications Contact 01/06/2017
REATA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/12/2013
Corporate Officer/Principal 01/03/2008
Corporate Officer/Principal 01/01/2005
Vedi nel dettaglio l'esperienza di Casi DeYoung

Formazione di Casi DeYoung

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

35

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Commercial Services

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Casi DeYoung